Letter: ciclosporin and vedolizumab for steroid‐refractory ulcerative colitis

of endogenous ACE2-Ang 1-7 axis activation. These data suggest that, in addition to the use of angiotensin receptor blockers and/or ACE inhibitors and/or ROCK inhibitors, vitamin D may also be beneficial to increase ACE2 and reduce ROCK activity. Furthermore, a telephone survey of over 100 of our Gitelman's and Bartter's patients, all of whom were from hotspots of the COVID-19 pandemic in Northern Italy, found none of them infected with COVID-19.10 This is significant evidence (95% CI 0%-3% compared to the estimated true COVID-19 prevalence in Northern Italy of 8.7%, 95% CI 8.7%-8.8%, P = 0.004), that increased ACE2 and reduced ROCK activity may have beneficial effects in COVID-19 prevention and/ or treatment. Given the rapidly evolving nature of the COVID-19 pandemic and in consideration of the reported effects of vitamin D on ACE2 and ROCK, vitamin D might also be used to reduce the severity of COVID-19.

[1]  D. Banerjee,et al.  Letter: does vitamin D have a potential role against COVID‐19? , 2020, Alimentary pharmacology & therapeutics.

[2]  P. Davis,et al.  Rho kinase inhibitors for SARS-CoV-2 induced acute respiratory distress syndrome: Support from Bartter’s and Gitelman’s syndrome patients , 2020, Pharmacological Research.

[3]  L. Calò,et al.  ROCK (RhoA/Rho Kinase) in Cardiovascular–Renal Pathophysiology: A Review of New Advancements , 2020, Journal of clinical medicine.

[4]  A. Panarese,et al.  Letter: Covid‐19, and vitamin D , 2020, Alimentary pharmacology & therapeutics.

[5]  G. Karimi,et al.  Plausibility of therapeutic effects of Rho kinase inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (COVID-19) , 2020, Pharmacological Research.

[6]  Yan Wang,et al.  Organ‐protective effect of angiotensin‐converting enzyme 2 and its effect on the prognosis of COVID‐19 , 2020, Journal of medical virology.

[7]  D. Rubin,et al.  Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid‐refractory ulcerative colitis , 2019, Alimentary pharmacology & therapeutics.

[8]  Minghui Zhu,et al.  Vitamin D attenuates myocardial ischemia–reperfusion injury by inhibiting inflammation via suppressing the RhoA/ROCK/NF‐ĸB pathway , 2019, Biotechnology and applied biochemistry.

[9]  Sergio Lavandero,et al.  Counter-regulatory renin–angiotensin system in cardiovascular disease , 2019, Nature Reviews Cardiology.

[10]  K. Farkas,et al.  New Promising Combo Therapy in Inflammatory Bowel Diseases Refractory to Anti-TNF Agents: Cyclosporine Plus Vedolizumab. , 2018, Journal of Crohn's & colitis.

[11]  P. Davis,et al.  Understanding the mechanisms of angiotensin II signaling involved in hypertension and its long-term sequelae: insights from Bartter's and Gitelman's syndromes, human models of endogenous angiotensin II signaling antagonism , 2014, Journal of hypertension.

[12]  K. Farkas,et al.  Long-term efficacy and safety of cyclosporine as a rescue therapy in acute, steroid-refractory severe ulcerative colitis: switching to infliximab is more effective than treating with concomitant immunomodulators. , 2011, Journal of clinical gastroenterology.

[13]  A. D'Angelo,et al.  ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: pathophysiological implications. , 2010, Journal of nephrology.